← Back to Insights
December 21, 2022
Authors
David Burda
Topics
Economics Outcomes System Dynamics
Channels
Blogs

Are You Going to Finish That (Prescription Drug)?

If you come to dinner at a casual or fast-food restaurant with my family, chances are, you’re going to hear someone say, “Are you going to finish that?” That someone usually is me.

It’s usually me for two reasons. One, I like food and will eat pretty much anything within arm’s reach if you’re not careful. Two, I hate waste. I mean, I absolutely hate waste of any kind. Leaving two fries on your plate is like leaving a half page-worth of ink in a cartridge or tossing out a box of fuzzy raspberries because we didn’t eat them within 15 seconds of bringing them home.

It’s not because I’m cheap or can’t afford it or grew up during the Great Depression. It’s because waste is just wrong.  You’re needlessly disposing something of value or something that has value to someone else. Think of all the water we waste as we wait for the water coming out of the shower head to get hot. Then think of all the people who have to walk miles just to get a gallon of clean water to drink.

Given that, you can’t imagine all my handwringing at a new study in JAMA Internal Medicine on wasted prescription drugs.

Researchers from Beth Israel Deaconess Medical Center and Harvard Medical School in Boston wanted to know how much Medicare spends on prescription drugs thrown away by providers who give them to beneficiaries with Medicare Part B coverage. Generally, these are injectable drugs given by physicians or other licensed clinicians to patients. The amount thrown away is the difference between the right dose for the patient and what’s left in the prepackaged vial or tube or bag after the patient gets the drug.

It’s like the two ounces of Diet Coke left in your 12-ounce can after you fill your 10-ounce glass. Except you don’t get to empty the can into your glass after you take a few sips.

Also, unlike leftover Diet Coke, federal law requires physicians and other clinicians to report leftover drug percentages to CMS on their Medicare Part B drug claims.

Using data reported to CMS, here’s what the researchers found: over the four-year study period, 2017 through 2020, providers threw out 2.2 percent of about 500 different types of administered drugs at a cost to Medicare of $3 billion. Further:

  • The percentage of discarded drugs rose to 2.3 percent in 2020 from 1.8 percent in 2017
  • The cost of the discarded drugs dropped to $719.2 million in 2020 from $736.9 million in 2017
  • Non-oncologic injectable and infusion drugs were the most frequently discarded drugs followed by chemotherapy drugs, “other” drugs and imaging drugs

In an accompanying editorial, two researchers who weren’t part of the study, one from Yale and the other from Vanderbilt, said the amount of prescription drug waste is likely underreported because physicians don’t have any strong incentives to report medication waste on their Medicare claims.

“The status quo is unsustainable, and it is incumbent on policy makers to act,” they said. “Decreasing waste, one way or another, can help us to avoid throwing away Medicare’s resources, saving money
and, more importantly, lives.”

The idea of expensive and potentially life-saving cancer drugs going to waste is particularly galling given the growing unaffordability of oncology care. Also galling is the fact that we’re paying drug companies to make something that’s not being used and providers to administer something that’s not being used.

Paying for and throwing away part of a good corned beef sandwich is one thing. Paying for and throwing away someone’s chance at life is another.

I hate waste.

Thanks for reading.

About the Author

David Burda

Dave Burda began covering healthcare in 1983 and hasn’t stopped since. Dave writes this monthly column “Burda on Healthcare,” contributes weekly blog posts, manages our weekly newsletter 4sight Friday, and hosts our weekly Roundup podcast. Dave believes that healthcare is a business like any other business, and customers—patients—are king. If you do what’s right for patients, good business results will follow.

Dave’s personal experiences with the healthcare system both as a patient and family caregiver have shaped his point of view. It’s also been shaped by covering the industry for 35 years as a reporter and editor. He worked at Modern Healthcare for 25 years, the last 11 as editor.

Prior to Modern Healthcare, he did stints at the American Medical Record Association (now AHIMA) and the American Hospital Association. After Modern Healthcare, he wrote a monthly column for Twin Cities Business explaining healthcare trends to a business audience, and he developed and executed content marketing plans for leading healthcare corporations as the editorial director for healthcare strategies at MSP Communications.

When he’s not reading and writing about healthcare, Dave spends his time riding the trails of DuPage County, IL, on his bike, tending his vegetable garden and daydreaming about being a lobster fisherman in Maine. He lives in Wheaton, IL, with his lovely wife of 35 years and his three children, none of whom want to be journalists or lobster fishermen.

 

Recent Posts

Economics
Cain Brothers House Calls Podcast: Communities Benefit from Access to Dental Health
Bridging the Gap  U.S. healthcare has long overlooked the essential role that dental care can play in providing… Read More
By and January 26, 2023
Consumerism
Burda on Healthcare: The Nays Have It. Healthcare Is Not Getting More Affordable for Consumers
As we start the new year, it’s time to ask the question once again: Has healthcare gotten any… Read More
By January 24, 2023
Economics
Keep Moving. Nothing to See Here. Just Another Double-Digit Increase in Medicare Advantage Spending
I’m starting to run out of clever headlines to tell the same story. Spending on Medicare Advantage plans… Read More
By January 18, 2023